Cargando…

Galápagosization of sepsis management in Japan: a nationwide survey of current practices

AIM: Sepsis treatment has been standardized in many countries worldwide. However, treatment of sepsis in Japan has developed independently, and how Japanese physicians actually treat sepsis patients nationwide remains uninvestigated. The aim of this study was to clarify the current practice for sept...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamakawa, Kazuma, Hasegawa, Daisuke, Yasuda, Hideto, Sakamoto, So, Nishida, Kazuki, Yatabe, Tomoaki, Egi, Moritoki, Ogura, Hiroshi, Nishida, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507569/ https://www.ncbi.nlm.nih.gov/pubmed/32999728 http://dx.doi.org/10.1002/ams2.561

Ejemplares similares

New avenues of sepsis research: obtaining perspective by analyzing and comparing SSCG 2021 and J-SSCG 2020
por: Yatabe, Tomoaki, et al.
Publicado: (2022)

Comparative Analysis of Three Machine-Learning Techniques and Conventional Techniques for Predicting Sepsis-Induced Coagulopathy Progression
por: Hasegawa, Daisuke, et al.
Publicado: (2020)

Clinical Significance of MicroRNAs in Patients with Sepsis: Protocol for a Systematic Review and Meta-Analysis
por: Hasegawa, Daisuke, et al.
Publicado: (2019)

Treatment of patients with sepsis in a closed intensive care unit is associated with improved survival: a nationwide observational study in Japan
por: Ogura, Takayuki, et al.
Publicado: (2018)

Japanese rapid/living recommendations on drug management for COVID‐19
por: Yamakawa, Kazuma, et al.
Publicado: (2021)

Anticoagulant therapies against sepsis‐induced disseminated intravascular coagulation
por: Umemura, Yutaka, et al.
Publicado: (2023)

Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)
por: Yamakawa, Kazuma, et al.
Publicado: (2021)

Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (July 2022)
por: Yamakawa, Kazuma, et al.
Publicado: (2022)

Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan
por: Yamakawa, Kazuma, et al.
Publicado: (2016)

β1-blocker in sepsis
por: Hasegawa, Daisuke, et al.
Publicado: (2021)

Nationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011–2013
por: Hayakawa, Mineji, et al.
Publicado: (2018)

Current status of antimicrobial prophylaxis during extracorporeal membrane oxygenation in Japan: a national survey
por: Hara, Yoshitaka, et al.
Publicado: (2021)

Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
por: Hasegawa, Daisuke, et al.
Publicado: (2019)

Non-linear and Interaction Analyses of Biomarkers for Organ Dysfunctions as Predictive Markers for Sepsis: A Nationwide Retrospective Study
por: Umemura, Yutaka, et al.
Publicado: (2022)

Efficacy of Carbapenems Compared With Noncarbapenem Broad-Spectrum Beta-Lactam Antibiotics as Initial Antibiotic Therapy Against Sepsis: A Nationwide Observational Study*
por: Umemura, Yutaka, et al.
Publicado: (2023)

Impact of Blood Type O on Mortality of Sepsis Patients: A Multicenter Retrospective Observational Study
por: Hasegawa, Daisuke, et al.
Publicado: (2020)

Glucose control using an artificial pancreas in a severe COVID-19 patient on extracorporeal membrane oxygenation: a case report
por: Hinoue, Takuya, et al.
Publicado: (2021)

Renal blood flow in sepsis
por: Langenberg, Christoph, et al.
Publicado: (2005)

Hematological Phenotype of COVID-19-Induced Coagulopathy: Far from Typical Sepsis-Induced Coagulopathy
por: Umemura, Yutaka, et al.
Publicado: (2020)

Age Is Associated With the Efficacy of Anticoagulant Therapies Against Sepsis-Induced Disseminated Intravascular Coagulation
por: Takahashi, Kyosuke, et al.
Publicado: (2021)

Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study
por: Umemura, Yutaka, et al.
Publicado: (2018)

Cefepime-induced encephalopathy in a COVID-19 patient: a case report
por: Nakamura, Tomoyuki, et al.
Publicado: (2022)

Investigation of factors affecting COVID-19 pancreatic injury: a single-center, retrospective study
por: Komatsu, Satoshi, et al.
Publicado: (2023)

Effect of multidisciplinary interventions in perioperative management center on duration of preoperative fasting: A single-center before-and-after study
por: Komatsu, Satoshi, et al.
Publicado: (2022)

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J‐SSCG 2016)
por: Nishida, Osamu, et al.
Publicado: (2018)

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016)
por: Nishida, Osamu, et al.
Publicado: (2018)

Acute glycemic control in diabetics. How sweet is oprimal? Con: Just as sweet as in nondiabetic is better
por: Egi, Moritoki
Publicado: (2018)

Enhanced Expression of Cell-Specific Surface Antigens on Endothelial Microparticles in Sepsis-Induced Disseminated Intravascular Coagulation
por: Matsumoto, Hisatake, et al.
Publicado: (2015)

Differential effect of lactate in predicting mortality in septic patients with or without disseminated intravascular coagulation: a multicenter, retrospective, observational study
por: Hasegawa, Daisuke, et al.
Publicado: (2019)

Tranexamic acid and trauma-induced coagulopathy
por: Nishida, Takeshi, et al.
Publicado: (2017)

Trends in sepsis care in Japan: comparison of two sepsis cohort studies conducted by the Japanese Association for Acute Medicine
por: Fujishima, Seitaro, et al.
Publicado: (2019)

Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study
por: Yamakawa, Kazuma, et al.
Publicado: (2011)

Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan
por: Yasui, Junichi, et al.
Publicado: (2016)

Time Trends of the Outcomes and Treatment Options for Disseminated Intravascular Coagulation: A Nationwide Observational Study in Japan
por: Yamakawa, Kazuma, et al.
Publicado: (2020)

The Optimal Glycemic Control in Patients with Diabetes in the ICU: Where Is the Sweet Spot?
por: Hermanides, Jeroen, et al.
Publicado: (2022)

Trends in the incidence and outcome of sepsis using data from a Japanese nationwide medical claims database-the Japan Sepsis Alliance (JaSA) study group-
por: Imaeda, Taro, et al.
Publicado: (2021)

Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan
por: Yamakawa, Kazuma, et al.
Publicado: (2011)

Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study
por: Matsuda, Naoyuki, et al.
Publicado: (2020)

Hour-1 bundle adherence was associated with reduction of in-hospital mortality among patients with sepsis in Japan
por: Umemura, Yutaka, et al.
Publicado: (2022)

Nurse teachers’ knowledge about epilepsy and communication issues between schools and medical institutions: A nationwide questionnaire survey in Japan
por: Terada, Kiyohito, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t6eualm6l78rl9sb831nlgnpbh